Concepedia

Ervin Finta

EF

7

Publications

3.7K

Citations

7

H-Index

1992

Active since

Affiliations

University of Freiburg(Current)

Eli Lilly (United States)

National Medical Research Center of Cardiology

Universidad De Santander

Central Clinical Hospital

Ervin Finta is an author at University of Freiburg specializing in medicine, neuroscience, and diabetes.

Top concepts

Publications per year

1992–2019

7

Publications

7

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with μ-opioid receptors

Jan Ševčı́k, Ervin Finta, Péter Illés · European Journal of Pharmacology · 1993 · 101 citations

, , +11

Depolarization of rat locus coeruleus neurons by adenosine 5′-triphosphate

Lutz Harms, Ervin Finta, Martin Tschöpl et al. · Neuroscience · 1992 · 91 citations

, , +6

Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones

Péter Illés, Ervin Finta, K Nieber · Naunyn-Schmiedeberg s Archives of Pharmacology · 1993 · 58 citations

, , +12

Rows per page

1–5 of 7